Science Explorer Back to mapMap
Institution · Cancer Research UK

Most cited papers from Cancer Research UK

What are the most cited papers from Cancer Research UK?

The most cited paper from Cancer Research UK is "Measuring inconsistency in meta-analyses" (Julian P. T. Higgins, Simon G. Thompson, Jonathan J Deeks et al., 2003), with 64,184 citations. Next come "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (11,535) and "Cancer-related inflammation" (11,477).

Showing 50 of 59 papers. Every paper with more than 2,501 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Measuring inconsistency in meta-analyses Julian P. T. Higgins, Simon G. Thompson, Jonathan J Deeks et al. · BMJ Open access 4 Sep 2003 64,184
2 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
3 Cancer-related inflammation Alberto Mantovani, Paola Allavena, Antonio Sica et al. · Nature Open access Jul 2008 11,477
4 Mutations of the BRAF gene in human cancer Helen Ruth Davies et al. · Nature Jun 2002 10,791
5 Signatures of mutational processes in human cancer Australian Pancreatic Cancer Genome Initiative et al. · Nature Open access 14 Aug 2013 10,284
6 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Paul R. Burton et al. · Nature Open access276 authors 6 Jun 2007 9,692
7 The MR-Base platform supports systematic causal inference across the human phenome Gibran Hemani, Jie Zheng, Benjamin L. Elsworth et al. · eLife Open access 30 May 2018 8,708
8 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman et al. · PLoS Medicine Open access 10 Oct 2007 8,626
9 Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing Marco Gerlinger et al. · New England Journal of Medicine Open access 7 Mar 2012 7,931
10 Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature Apr 2005 6,785
11 Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 Lorenzo Galluzzi et al. · Cell Death and Differentiation Open access169 authors 23 Jan 2018 6,760
12 The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups METABRIC Group et al. · Nature Open access 17 Apr 2012 6,505
13 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors 2 Jan 2016 6,023
14 Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine 6 Oct 2004 5,779
15 Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer Jean‐Charles Soria et al. · New England Journal of Medicine Open access 18 Nov 2017 5,475
16 Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Andrew G. Renehan, Margaret Tyson, Matthias Egger et al. · The Lancet Review Feb 2008 5,283
17 Rho GTPases in cell biology Sandrine Etienne‐Manneville, Alan K. Hall · Nature Dec 2002 4,844
18 Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access 21 Mar 2018 4,756
19 Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents Philip L. Ross, Yulin Huang, Jason Marchese et al. · Molecular & Cellular Proteomics Open access 22 Sep 2004 4,464
20 Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia Catherine D. Nobes, Alan K. Hall · Cell Open access Apr 1995 4,456
21 N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO Guifang Jia, Ye Fu, Xu Zhao et al. · Nature Chemical Biology Open access 16 Oct 2011 4,230
22 Succinate is an inflammatory signal that induces IL-1β through HIF-1α Gillian M. Tannahill et al. · Nature Open access 22 Mar 2013 4,197
23 Guidelines for the use and interpretation of assays for monitoring autophagy Daniel J. Klionsky et al. · Autophagy Open access1,270 authors Apr 2012 4,068
24 A framework for advancing our understanding of cancer-associated fibroblasts Erik A. Sahai et al. · Nature reviews. Cancer ReviewOpen access 24 Jan 2020 3,962
25 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses Hiroki Kato, Osamu Takeuchi, Shintaro Sato et al. · Nature 9 Apr 2006 3,913
26 The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature Open access1,384 authors 5 Feb 2020 3,854
27 Genomic analyses identify molecular subtypes of pancreatic cancer Peter J. Bailey et al. · Nature 103 authors 23 Feb 2016 3,805
28 Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies Antonis C. Antoniou et al. · The American Journal of Human Genetics Open access 23 Apr 2003 3,727
29 Regulation of Wound Healing by Growth Factors and Cytokines Sabine Werner, Richard Philip Grose · Physiological Reviews Review Jul 2003 3,647
30 Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA Sandra S. Diebold, Tsuneyasu Kaisho, Hiroaki Hemmi et al. · Science 23 Feb 2004 3,453
31 Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature Open access1,324 authors 5 Feb 2020 3,360
32 Cellular Senescence: Defining a Path Forward Vassilis G. Gorgoulis et al. · Cell Open access Oct 2019 3,322
33 Targeting RAS signalling pathways in cancer therapy Julian Downward · Nature reviews. Cancer Review 2003 3,287
34 Blinded by the Light: The Growing Complexity of p53 Karen H. Vousden, Carol L. Prives · Cell Open access May 2009 3,205
35 Interaction revisited: the difference between two estimates Douglas G. Altman, J Martin Bland · BMJ Open access 23 Jan 2003 3,202
36 Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer Kenneth P. Olive et al. · Science Open access 21 May 2009 3,195
37 Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade Nicholas McGranahan et al. · Science Open access 3 Mar 2016 3,177
38 Patterns of somatic mutation in human cancer genomes Christopher D. Greenman et al. · Nature Open access Mar 2007 3,167
39 The extracellular matrix: A dynamic niche in cancer progression Pengfei Lu, Valerie Marie Weaver, Zena Werb · The Journal of Cell Biology Open access 20 Feb 2012 3,079
40 RHO GTPASES: Biochemistry and Biology Aron B. Jaffe, Alan K. Hall · Annual Review of Cell and Developmental Biology Review 28 Jun 2005 3,071
41 MAP kinase signalling pathways in cancer Amardeep S. Dhillon, Suzanne Hagan, Oliver Rath et al. · Oncogene 14 May 2007 3,062
42 Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families Deborah Ford et al. · The American Journal of Human Genetics Open access Mar 1998 3,057
43 Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future Nicholas McGranahan, Charles Swanton · Cell Open access Feb 2017 3,002
44 EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent Nicolas Mottet et al. · European Urology Open access 7 Nov 2020 2,876
45 Liquid biopsies come of age: towards implementation of circulating tumour DNA Jonathan C. M. Wan, Charles E. Massie, Javier García-Corbacho et al. · Nature reviews. Cancer ReviewOpen access 24 Feb 2017 2,855
46 Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF Paul Wan, Mathew J. Garnett, Stephen Mark Roe et al. · Cell Open access Mar 2004 2,841
47 Basic and Therapeutic Aspects of Angiogenesis Michael Potente, Holger Gerhardt, Peter Carmeliet · Cell Open access Sep 2011 2,838
48 Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors Laleh Haghverdi, Aaron T. L. Lun, Michael David Morgan et al. · Nature Biotechnology Open access 2 Apr 2018 2,808
49 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman et al. · Epidemiology Open access Nov 2007 2,777
50 The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates Stephen D. Roughley, Allan Michael Jordan · Journal of Medicinal Chemistry 19 Apr 2011 2,771

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.